|
|
Volumn 72, Issue 6, 2003, Pages 361-362
|
|
Prescribing cyclic antidepressants for vitiligo patients: Which agents are superior, which are not? [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCHOLINESTERASE;
AMINE OXIDASE (FLAVIN CONTAINING);
AMITRIPTYLINE;
CATECHOL METHYLTRANSFERASE;
CATECHOLAMINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DESIPRAMINE;
MAPROTILINE;
NORADRENALIN UPTAKE INHIBITOR;
PROTRIPTYLINE;
TETRACYCLIC ANTIDEPRESSANT AGENT;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIMIPRAMINE;
CALCIUM CELL LEVEL;
CATECHOLAMINE RELEASE;
COMPARATIVE STUDY;
DRUG POTENCY;
HUMAN;
INSOMNIA;
LETTER;
MAJOR DEPRESSION;
PATHOGENESIS;
PHARMACODYNAMICS;
PRESCRIPTION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
VITILIGO;
ADRENERGIC UPTAKE INHIBITORS;
AMITRIPTYLINE;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
CHOLINERGIC ANTAGONISTS;
DEPRESSIVE DISORDER, MAJOR;
DESIPRAMINE;
HUMANS;
NOREPINEPHRINE;
RECEPTORS, MUSCARINIC;
SLEEP INITIATION AND MAINTENANCE DISORDERS;
TREATMENT OUTCOME;
TRIMIPRAMINE;
VITILIGO;
|
|
EID: 0142120688
PISSN: 00333190
EISSN: None
Source Type: Journal
DOI: 10.1159/000073036 Document Type: Letter |
|
Times cited : (15)
|
|
References (6)
|
